Cumulatively, these findings demonstrate that 6-gingerol exerts its anti-adipogenic and anti-lipogenic effects by suppressing the synergistic activation of PPARγ, C/EBPα, and SREBP-1, thereby contributing to the amelioration of adiposity in HFD-induced obesity. Here, CEBPA is linked to obesity disorder.